| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | Chief Commercial Officer | Common Stock | 456,338 | $2,423,155 | $5.31 | 06 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 06 Aug 2024 | 1 | -$96,902 | 4 | Chief Commercial Officer | 08 Aug 2024, 16:06 |
| AUPH | Aurinia Pharmaceuticals Inc. | 06 Mar 2024 | 1 | -$99,551 | 4 | Chief Commercial Officer | 07 Mar 2024, 16:42 |
| AUPH | Aurinia Pharmaceuticals Inc. | 20 Feb 2024 | 2 | -$86,951 | 4 | Chief Commercial Officer | 22 Feb 2024, 16:33 |
| AUPH | Aurinia Pharmaceuticals Inc. | 02 Mar 2023 | 1 | $0 | 4 | Chief Commercial Officer | 06 Mar 2023, 15:28 |
| AUPH | Aurinia Pharmaceuticals Inc. | 09 Nov 2022 | 1 | +$25,075 | 4 | Chief Commercial Officer | 14 Nov 2022, 15:31 |
| AUPH | Aurinia Pharmaceuticals Inc. | 01 Aug 2022 | 2 | $0 | 4 | Chief Commercial Officer | 01 Aug 2022, 16:13 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 Jul 2022 | 0 | $0 | 3 | Chief Commercial Officer | 19 Jul 2022, 17:33 |